These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 34295678)

  • 1. Exploring natural killer cell immunology as a therapeutic strategy in lung cancer.
    Hess JB; Sutherland KD; Best SA
    Transl Lung Cancer Res; 2021 Jun; 10(6):2788-2805. PubMed ID: 34295678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous Immune Enhancement Therapy for Cancer - Our experience since 2004.
    Terunuma H
    J Stem Cells Regen Med; 2012; 8(3):205-6. PubMed ID: 24693200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell-based strategies for immunotherapy of cancer.
    Vaněk O; Kalousková B; Abreu C; Nejadebrahim S; Skořepa O
    Adv Protein Chem Struct Biol; 2022; 129():91-133. PubMed ID: 35305726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Natural Killer Cells for Tumor Immunotherapy.
    Zhang C; Hu Y; Shi C
    Front Immunol; 2020; 11():60. PubMed ID: 32140153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell-mediated immunosurveillance of human cancer.
    Malmberg KJ; Carlsten M; Björklund A; Sohlberg E; Bryceson YT; Ljunggren HG
    Semin Immunol; 2017 Jun; 31():20-29. PubMed ID: 28888619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy.
    Shaver KA; Croom-Perez TJ; Copik AJ
    Front Immunol; 2021; 12():679117. PubMed ID: 33995422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells: a promising immunotherapy for cancer.
    Chu J; Gao F; Yan M; Zhao S; Yan Z; Shi B; Liu Y
    J Transl Med; 2022 May; 20(1):240. PubMed ID: 35606854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing NK Cells for Cancer Treatment.
    Minetto P; Guolo F; Pesce S; Greppi M; Obino V; Ferretti E; Sivori S; Genova C; Lemoli RM; Marcenaro E
    Front Immunol; 2019; 10():2836. PubMed ID: 31867006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors.
    Chen Z; Yang Y; Liu LL; Lundqvist A
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31340613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing NK cells for cancer immunotherapy: immune checkpoint receptors and chimeric antigen receptors.
    Kim N; Lee DH; Choi WS; Yi E; Kim H; Kim JM; Jin HS; Kim HS
    BMB Rep; 2021 Jan; 54(1):44-58. PubMed ID: 33298244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Natural killer (NK) cell and immunotherapy].
    Iino T; Takaishi S
    Nihon Rinsho; 2017 Feb; 75(2):306-311. PubMed ID: 30562869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cells and cancer therapy, what we know and where we are going.
    Ghaemdoust F; Keshavarz-Fathi M; Rezaei N
    Immunotherapy; 2019 Oct; 11(14):1231-1251. PubMed ID: 31422725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cells as a promising therapeutic target for cancer immunotherapy.
    Kim N; Lee HH; Lee HJ; Choi WS; Lee J; Kim HS
    Arch Pharm Res; 2019 Jul; 42(7):591-606. PubMed ID: 30895524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies.
    Matosevic S
    J Immunol Res; 2018; 2018():4054815. PubMed ID: 30306093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?
    Ben-Shmuel A; Biber G; Barda-Saad M
    Front Immunol; 2020; 11():275. PubMed ID: 32153582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities.
    Hu W; Wang G; Huang D; Sui M; Xu Y
    Front Immunol; 2019; 10():1205. PubMed ID: 31214177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell engineering - a new hope for cancer immunotherapy.
    Lin CY; Gobius I; Souza-Fonseca-Guimaraes F
    Semin Hematol; 2020 Oct; 57(4):194-200. PubMed ID: 33256912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review).
    Zeng Y; Lv X; Du J
    Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34498710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Killer Cells and Dendritic Cells: Expanding Clinical Relevance in the Non-Small Cell Lung Cancer (NSCLC) Tumor Microenvironment.
    Ahluwalia P; Ahluwalia M; Mondal AK; Sahajpal NS; Kota V; Rojiani MV; Kolhe R
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The War Is on: The Immune System against Glioblastoma-How Can NK Cells Drive This Battle?
    da Silva LHR; Catharino LCC; da Silva VJ; Evangelista GCM; Barbuto JAM
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.